Cutaneous melanoma: Update on prevention, screening, diagnosis, and treatment

American Family Physician

Volumn 72, Issue 2, 2005, Pages 269-276

  Rager, Erika L ^a,b   Bridgeford, Edward P ^a,b   Ollila, David W ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CONGENITAL NEVUS; DYSPLASTIC NEVUS; EXCISION; FAMILY HISTORY; FOLLOW UP; HEALTH PROGRAM; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MELANOMA; OCCUPATIONAL EXPOSURE; PROGNOSIS; RACE DIFFERENCE; RADIATION EXPOSURE; REVIEW; RISK FACTOR; SELF EXAMINATION; SKIN CANCER; SOLAR RADIATION; TREATMENT INDICATION;

FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS; UNITED STATES;

EID: 22544463094     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Cancer facts and figures 2005. Atlanta: American Cancer Society, 2005. Accessed online February 20, 2005, at: http://www.cancer. org/downloads/STT/ estimated_new_cancer_cases_and_deaths_by_ sex_for_all_sites._US._2005.pdf.
2. Ries LA, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al., eds. SEER cancer statistics review, 1973-1999. Bethesda, Md.: National Cancer Institute, 2002. Accessed online November 9, 2004, at: http://seer. cancer.gov/csr/1973_1999/.
3. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988-93. Cancer Causes Control 1997;8:246-52.
4. American Academy of Dermatology. MelanomaNet. Accessed online November 9, 2004, at: http://www.skincarephysicians.com/melanomanet/.
5. Helfand M, Krages KP. Counseling to prevent skin cancer: a summary of the evidence for the U.S. Preventive Services Task Force. Rockville, Md.: Agency for Healthcare Research and Quality, 2003. Accessed November 9, 2004, at: http://www.ahrq.gov/clinic/3rduspstf/skcacoun/skcounsum.htm.
6. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001;12:69-82.
7. Helfand M, Mahon SM, Eden KB, Frame PS, Orleans CT. Screening for skin cancer. Am J Prev Med 2001;20(3 suppl):47-58.
8. U.S. Preventive Services Task Force. Screening for skin cancer: recommendations and rationale. Am J Prev Med 2001;20(3 suppl):44-6.
9. Summary of policy recommendations for periodic health examinations. August 2004. Accessed online March 11, 2005, at: http://www.aafp. org/PreBuilt/PHErev56.pdf.
10. Skin cancer: saving your skin from sun damage. Accessed online March 11, 2005, at: http://familydoctor.org/159.xml.
11. American Academy of Dermatology Practice Management. Guidelines for care of primary cutaneous melanoma. Accessed online November 9, 2004, at: http://www.aadassociation.org/Guidelines/CutaneousMel.html.
12. Ferrini RL, Perlman M, Hill L. American College of Preventive Medicine policy statement: screening for skin cancer. Am J Prev Med 1998;14: 80-2.
13. Ferrini RL, Perlman M, Hill L. American College of Preventive Medicine practice policy statement: skin protection from ultraviolet light exposure. The American College of Preventive Medicine. Am J Prev Med 1998;14:83-6.
14. National Cancer Institute. Skin cancer (PDQ): screening, health professional version. Accessed online March 11, 2005, at: http://cancer. gov/cancerinfo/pdq/screening/skin/healthprofessional.
15. Field MJ, Lawrence RS, Zwanziger L, eds., for the Institute of Medicine. Extending Medicare coverage for preventive and other services. Washington, D.C.: National Academy Press, 2000.
16. Feightner JW. Prevention of skin cancer. In: Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa, Canada: Canada Communication Group-Publishing, 1994:850-9.
17. American Cancer Society. How is melanoma skin cancer found? Accessed online March 11, 2005, at: http://www.cancer.org/docroot/CRI/content/ CRI_2_2_3X_How_is_melanoma_skin_cancer_found_ 50.asp?sitearea=.
18. NIH Consensus Development Panel on Early Melanoma. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-9.
19. Rigel DS, Carucci JA. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin 2000;50:215-36.
20. Geller AC, Sober AJ, Zhang Z, Brooks DR, Miller DR, Halpern A, et al. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Screening Program. Cancer 2002;95:1554-61.
21. Harbauer A, Binder M, Pehamberger H, Wolff K, Kittler H. Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk. Melanoma Res 2003;13:537-42.
22. Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Johnson TM. Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer 2002;95:1562-8.
23. Aitken JF, Elwood JM, Lowe JB, Firman DW, Balanda KP, Ring IT. A randomised trial of population screening for melanoma. J Med Screen 2002;9:33-7.
24. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996;88:17-23.
25. Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physical examination and self-examination of the skin. CA Cancer J Clin 1985;35:130-51.
26. Whited JD, Grichnik JM, The rational clinical examination. Does this patient have a mole or a melanoma? JAMA 1998;279:696-701.
27. Balch CM, ed. Cutaneous melanoma. 3d ed. St. Louis: Quality Medical Publishing, 1998:89.
28. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Version 1.2004. Accessed online November 9, 2004, at: http://www.nccn.org/professionals/physicians_gls/.
29. Lens MB, Dawes M, Goodacre T, Bishop JA. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002;137:1101-5.
30. Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 2001;8:101-8.
31. Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87-97.
32. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
33. Leong WL, Ghazarian DM, McCready DR. Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity. J Surg Oncol 2003;82:143-6.
34. Blum A, Brand CU, Ellwanger U, Schlagenhauff B, Stroebel W, Rassner G, et al. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol 1999;141:783-7.
35. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7-17.
36. Wheatley K, Ives N, Hancock B, Gore M, Eggermont A, Suciu S. Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials. Cancer Treat Rev 2003;29:241-52.
37. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Castinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-34.
38. Dessureault S, Soong SJ, Ross MI, Thompson JF, Kirkwood JM, Gershenwald JE, et al. Improved staging cf node-negative patients with intermediate to thick melanomas (> 1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy [published correction appears in Ann Surg Oncol 2002;9:318]. Ann Surg Oncol 2001;8:766-70.
39. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer 1998;83:1664-78.
40. Schmid-Wendtner MH, Baumert J, Wendtner CM, Plewig G, Volkenandt M. Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 2001;145:981-5.
41. Goggins WB, Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 2003;97:639-43.
42. U.S. Preventive Services Task Force. Counseling to prevent skin cancer: recommendations and rationale. Rockville, Md.: Agency for Healthcare Research and Quality, 2003. Accessed online November 9, 2004, at: http://www.ahrq.gov/ clinic/3rduspstf/skcacoun/skcarr.htm.
43. Saraiya M, Glanz K, Briss P, Nichols P, White C, Das D. Preventing skin cancer: findings of the Task Force on Community Preventive Services on Reducing Exposure to Ultraviolet Light. MMWR Recomm Rep 2003;52(RR-15):1-12.